Untargeted mass spectrometric approach in metabolic healthy offspring of patients with type 2 diabetes reveals medium-chain acylcarnitine as potential biomarker for lipid induced glucose intolerance (LGIT).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jorg Kotzka Jens Fuchser |
| Publication date | July 2, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |